Discover open access scientific publications

Search, annotate, share and cite publications

Publications by John G. Gribben

Endothelial-Cell FAK Targeting Sensitizes Tumours to DNA-damaging Therapy

Nature

Multidisciplinary

2014

English

Update on Therapy of Chronic Lymphocytic Leukemia

Journal of Clinical Oncology

English

HIV Status Does Not Influence Outcome in Patients With Classical Hodgkin Lymphoma Treated With Chemotherapy Using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the Highly Active Antiretroviral Therapy Era

Journal of Clinical Oncology

English

Phase 1b Study of Venetoclax-Obinutuzumab in Previously Untreated and Relapsed/Refractory Chronic Lymphocytic Leukemia

English

Microenvironment Abnormalities and Lymphomagenesis: Immunological Aspects

Seminars in Cancer Biology

Cancer Research

2015

English

Programmed Cell Death Protein-1 (PD1) Expression in the Microenvironment of Classical Hodgkin Lymphoma Is Similar Between Favorable and Adverse Outcome and Does Not Enrich Over Serial Relapses With Conventional Chemotherapy

Haematologica

Hematology

2018

English

Durable Graft-Versus-Leukaemia Effects Without Donor Lymphocyte Infusions - Results of a Phase II Study of Sequential T-Replete Allogeneic Transplantation for High-Risk Acute Myeloid Leukaemia and Myelodysplasia

British Journal of Haematology

Hematology

2017

English

Acquired Chromosomal Anomalies in Chronic Lymphocytic Leukemia Patients Compared With More Than 50,000 Quasi-Normal Participants

English

Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)

Current Hematologic Malignancy Reports

English

Cytogenetic Prioritization With Inclusion of Molecular Markers Predicts Outcome in Previously Untreated Patients With Chronic Lymphocytic Leukemia Treated With Fludarabine or Fludarabine Plus Cyclophosphamide: A Long-Term Follow-Up Study of the US Intergroup Phase III Trial E2997

Leukemia and Lymphoma

English

Amanote Research

Discover open access scientific publications

Search, annotate, share and cite publications

Publications by John G. Gribben

Endothelial-Cell FAK Targeting Sensitizes Tumours to DNA-damaging Therapy

Update on Therapy of Chronic Lymphocytic Leukemia

HIV Status Does Not Influence Outcome in Patients With Classical Hodgkin Lymphoma Treated With Chemotherapy Using Doxorubicin, Bleomycin, Vinblastine, and Dacarbazine in the Highly Active Antiretroviral Therapy Era

Phase 1b Study of Venetoclax-Obinutuzumab in Previously Untreated and Relapsed/Refractory Chronic Lymphocytic Leukemia

Microenvironment Abnormalities and Lymphomagenesis: Immunological Aspects

Programmed Cell Death Protein-1 (PD1) Expression in the Microenvironment of Classical Hodgkin Lymphoma Is Similar Between Favorable and Adverse Outcome and Does Not Enrich Over Serial Relapses With Conventional Chemotherapy

Durable Graft-Versus-Leukaemia Effects Without Donor Lymphocyte Infusions - Results of a Phase II Study of Sequential T-Replete Allogeneic Transplantation for High-Risk Acute Myeloid Leukaemia and Myelodysplasia

Acquired Chromosomal Anomalies in Chronic Lymphocytic Leukemia Patients Compared With More Than 50,000 Quasi-Normal Participants

Immunotherapy in Chronic Lymphocytic Leukaemia (CLL)

Cytogenetic Prioritization With Inclusion of Molecular Markers Predicts Outcome in Previously Untreated Patients With Chronic Lymphocytic Leukemia Treated With Fludarabine or Fludarabine Plus Cyclophosphamide: A Long-Term Follow-Up Study of the US Intergroup Phase III Trial E2997